Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay

Prenatal Diagnosis

Volumn 23, Issue 1, 2003, Pages 1-5

  Talbot, J A ^a,c   Spencer, K ^b   Abushoufa, R A ^a  

^a HOPE HOSPITAL   (United Kingdom)

^b HAROLD WOOD HOSPITAL   (United Kingdom)

^c Medeval Ltd   (United Kingdom)

Author keywords

AFP; Free hCG; Prenatal screening; Total hCG; Trisomy 21

Indexed keywords

ALPHA FETOPROTEIN; BIOCHEMICAL MARKER; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; LECTIN; SIALIC ACID;

ADULT; ARTICLE; BIOCHEMISTRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOWN SYNDROME; FEMALE; GONADOTROPIN BLOOD LEVEL; HORMONE STRUCTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; LECTIN BINDING; MATERNAL AGE; MATERNAL SERUM; POPULATION RISK; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; SAMPLING; SECOND TRIMESTER PREGNANCY; STANDARDIZATION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; IMMUNOASSAY; LECTINS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS;

EID: 12244261028     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.507     Document Type: Article

References (28)

1. Abushoufa RA, Talbot JA, Brownbill K, Rafferty B, Kane JW, Robertson WR. 2000. The development of a sialic acid specific lectin-immunoassay for the measurement of human chorionic gonadotrophin glycoforms in serum and its application in normal and Down syndrome pregnancies. Clin Endocrinol 52: 499-508.
2. Bhavanandan V, Katlic AW. 1979. The interaction of wheat germ-agglutinin with sialoglycoproteins (the role of sialic acid). J Biol Chem 254: 4000-4008.
3. Birken S, Krichevsky A, O'Connor J, et al. 1999. Development and characterization of antibodies to a nicked and hyperglycosylated form of hCG from a choriocarcinoma patient: generation of antibodies that differentiate between pregnancy hCG and choriocarcinoma hCG. Endocr J 10: 137-144.
4. Cole LA. 1997. Immunoassay of hCG, its free subunits and metabolites. Clin Chem 43: 2233-2243.
5. Cole LA, Cermik D, Bahado-Singh RO. 1997. Oligosaccharide variants of hCG-related molecules: potential screening markers for Down syndrome. Prenat Diagn 17: 1188-1190.
6. Cole LA, Omrani A, Cermik D, Bahado-Singh RO, Mahoney MJ. 1998. Hyperglycosylated hCG, a potential alternative to hCG in Down syndrome screening. Prenat Diagn 18: 926-933.
7. Cole LA, Shahabi S, Oz UA, et al. 1999a. Urinary screening tests for fetal Down syndrome: II hyperglycosylated hCG. Prenat Diagn 19: 351-359.
8. Cole LA, Shahabi S, Oz UA, Bahdo-Singh R, Mahoney MJ. 1999b. Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: a new basis for gestational Down syndrome screening. Clin Chem 45: 2109-2119.
9. Cuckle HS, Wald NJ, Thompson SG. 1987. Estimating a woman's risk of having a pregnancy associated with Down syndrome using her age and serum alpha fetoprotein levels. Br J Obstet Gynaecol 94: 387-402.
10. Cuckle HS, Iles RK, Chard T. 1994. Urinary β-core human chorionic gonadotrophin: a new approach to Down syndrome screening. Prenat Diagn 14: 953-958.
11. Cuckle HS, Iles RK, Sehmi IH, et al. 1995. Urinary multiple marker screening for Down syndrome. Prenat Diagn 15: 745-751.
12. Cuckle HS, Canick JA, Kellner LH. 1999a. Collaborative study of maternal urine β-core human chorionic gonadotrophin screening for Down syndrome. Prenat Diagn 19: 911-917.
13. Cuckle HS, Shahabi S, Sehmi IK, Jones R, Cole LA. 1999b. Maternal urine hyperglycosylated hCG in pregnancies with Down syndrome. Prenat Diagn 19: 918-920.
14. Elliott M, Kardana A, Lustbader JW, Cole LA. 1997. Carbohydrate and peptide structure of the α- and β- subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma. Endocrine 7: 15-32.
15. Hsu JJ, Spencer K, Aitken DA, et al. 1999. Urinary free beta hCG, beta core fragment and total oestriol as markers of Down syndrome in the second trimester of pregnancy. Prenat Diagn 19: 148-158.
16. Ming-Chuan Shao. 1992. The use of streptavidin-biotinylglycans as a tool for characterization of oligosaccharide binding specificity of lectin. Anal Biochem 205: 77-82.
17. Monsigny M, Roche A, Sene C, Maget-Dana R, Delmotte F. 1980. Sugar-lectin interactions. How does wheat germ agglutinin bind sialoglycoconjugates. Eur J Biochem 104: 147-153.
18. Neveux LM, Palomaki GE, Larrivee DA, Knight GJ, Haddow JE. 1996. Refinements in managing maternal weight adjustment for interpreting prenatal screening results. Prenat Diagn 16: 1115-1119.
19. Office for National Statistics. 1997-1999. 1997,1998,1999 Birth Statistics Series FM1, Number 26,27,28. HMSO: London.
20. Royston P, Thompson SG. 1992. Model based screening by risk with application to Down syndrome screening. Stat Med 111: 257-268.
21. Shahabi S, Oz UA. Bahado-Singh RO, et al. 1999. Serum hyperglycosylated hCG: a potential screening test for fetal Down syndrome. Prenat Diagn 19: 488, 489.
22. Spencer K. Coombes EJ, Mallard AS, Ward AM. 1992. Free beta human choriogonadotropin in Down syndrome screening: a multicentre study of its role compared with other biochemical markers. Ann Clin Biochem 29: 506-518.
23. Spencer K. 1999. Second trimester prenatal screening for Down syndrome using alpha-fetoprotein and free beta hCG: a seven year review. Br J Obstet Gynaecol 106: 1287-1293.
24. Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH. 1999. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 13: 231-237.
25. Spencer K, Berry E, Crossley JA, Aitken DA, Nicolaides KH. 2000a. Is maternal serum total hCG a marker of trisomy 21 in the first trimester of pregnancy. Prenat Diagn 20: 311-317.
26. Spencer K, Talbot JA, Abushoufa RA. 2002. Maternal serum hyperglycosylated hCG in the first trimester of pregnancies affected by Down syndrome, using a sialic acid specific lectin immunoassay. Prenat Diagn 22: 656-662.
27. Wald NJ, Kennard A, Hackshaw A, McGuire A. 1997. Antenatal screening for Down syndrome. J Med Screen. 4: 181-246.
28. Weinans MJN, Butler SA, Mantingh A, Cole LA. 2000. Urinary hyperglycosylated hCG in first trimester screening for chromosomal abnormalities. Prenat Diagn 20: 976-978.